Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (21-30 of 418) with videos related to

Pageof 42
Sort By:
Lancet (London, England)|April 11, 2003
PsoriasisMark Lebwohl
Journal of the American Academy of Dermatology|June 22, 2005
A clinician's paradigm in the treatment of psoriasisMark Lebwohl
Journal of the American Academy of Dermatology|December 18, 2007
The effect of weight on the efficacy of biologic therapy in patients with psoriasisLily Clark, Mark Lebwohl
Journal of the American Academy of Dermatology|September 25, 2002
Imiquimod cream in the treatment of actinic keratosesAndrea Persaud, Mark Lebwohl
International Journal of Dermatology|June 7, 2007
Patient education and regular surveillance results in earlier diagnosis of second primary melanomaAnnemarie Uliasz, Mark Lebwohl
Journal of Drugs in Dermatology : JDD|May 18, 2006
New roles for systemic retinoidsMark Lebwohl, Martin Kathryn
International Journal of Dermatology|April 7, 2005
Complications of the smallpox vaccineBenjamin Schwartz, Mark Lebwohl
Dermatologic Therapy|February 19, 2009
New biologics for psoriasis and psoriatic arthritisMariya Rozenblit, Mark Lebwohl
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
TNF inhibitors for psoriasisMargot Chima, Mark Lebwohl
Journal of Drugs in Dermatology : JDD|August 22, 2020
Treating Scalp Psoriasis with Calcipotriene/Betamethasone Dipropionate Fixed-dose Combination Cutaneous Foam: Review of Phase 2 DataBibi Petersen, Mark Lebwohl
Pageof 42

Showing results (21-30 of 418) with videos related to

Sort By:
Pageof 42
Lancet (London, England)|April 11, 2003
PsoriasisMark Lebwohl
Journal of the American Academy of Dermatology|June 22, 2005
A clinician's paradigm in the treatment of psoriasisMark Lebwohl
Journal of the American Academy of Dermatology|December 18, 2007
The effect of weight on the efficacy of biologic therapy in patients with psoriasisLily Clark, Mark Lebwohl
Journal of the American Academy of Dermatology|September 25, 2002
Imiquimod cream in the treatment of actinic keratosesAndrea Persaud, Mark Lebwohl
International Journal of Dermatology|June 7, 2007
Patient education and regular surveillance results in earlier diagnosis of second primary melanomaAnnemarie Uliasz, Mark Lebwohl
Journal of Drugs in Dermatology : JDD|May 18, 2006
New roles for systemic retinoidsMark Lebwohl, Martin Kathryn
International Journal of Dermatology|April 7, 2005
Complications of the smallpox vaccineBenjamin Schwartz, Mark Lebwohl
Dermatologic Therapy|February 19, 2009
New biologics for psoriasis and psoriatic arthritisMariya Rozenblit, Mark Lebwohl
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
TNF inhibitors for psoriasisMargot Chima, Mark Lebwohl
Journal of Drugs in Dermatology : JDD|August 22, 2020
Treating Scalp Psoriasis with Calcipotriene/Betamethasone Dipropionate Fixed-dose Combination Cutaneous Foam: Review of Phase 2 DataBibi Petersen, Mark Lebwohl
Pageof 42